Developer docs
API playgroundTry for free, no card

Search company profiles

Savvy

Full company profile

uuid0005g3f

Namestring
Savvy
Legal namestring
Real Patients
Websiteurl
savvy.coop
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Real Patients (formerly Savvy Cooperative) is a patient insights platform founded in 2016 by Jen Horonjeff, PhD and Ronnie Sharpe that connects individuals living with health conditions to pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare technology companies seeking structured patient input for research and product development. The company operates a verified patient community spanning 2,500+ health conditions, including rare diseases and chronic illnesses, with 16,666+ patient experiences contributed cumulatively. Co-founders, both chronic illness patients themselves, built the platform to address what they identified as systematic underrepresentation of authentic patient perspectives in healthcare development decisions. The company rebranded from Savvy Cooperative to Real Patients in 2025-2026 to better reflect its patient-experience mission while retaining the same operating team and values.

The platform's core technology consists of a patient profile verification system, an activity-matching algorithm that routes patients to relevant research opportunities based on health conditions, and HIPAA-compliant data protection infrastructure with bank-level encryption. Patients create verified profiles through self-service signup, are matched to research engagements, and participate through three paid activity types: 30-minute research surveys ($75 each), 1-hour video focus groups ($150 each), and quarterly advisory boards ($500 each). The platform enforces consent-based data sharing where personal contact information remains protected and only de-identified responses are shared with approved research partners.

Real Patients operates a B2B2C transactional revenue model, earning transaction fees on each completed patient engagement. Enterprise sales are conducted through direct, founder-led relationships with pharmaceutical and healthcare buyers, supplemented by earned media coverage in healthcare publications including STAT News, FierceBiotech, CNBC, and Entrepreneur Magazine, and industry conference participation. The named customer roster exceeds 20 enterprise clients concentrated in pharmaceutical (Pfizer, Merck, Johnson & Johnson, AbbVie, AstraZeneca, Bristol-Myers Squibb, Sanofi, Roche, Eli Lilly, Novartis, Novo Nordisk, GSK, Takeda, Gilead, Amgen, Bayer, Boehringer Ingelheim, Regeneron, Moderna, Biogen), medical devices (Medtronic), and technology (Amazon, Salesforce). The company has received non-equity or small-equity support from MassChallenge and Indie.vc in 2020, with no disclosed institutional venture funding rounds.

Short descriptiontext

Real Patients (formerly Savvy Cooperative) is a HIPAA-compliant patient insights platform connecting a verified community across 2,500+ health conditions with pharmaceutical, biotech, and healthcare companies for paid research engagements.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSunnyside, United States
HQ citystring
Sunnyside
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
patient insights platform, healthcare market research, patient experience research, clinical research services, patient engagement network
Industry1 code
PRIMARYHLACAEAK
Patient Community, Peer Support & Social Engagement
Healthcare & Life Sciences/Digital Health & Health IT/Patient Engagement, CRM & Experience Platforms
NAICS code1 code
  • Offices of Other Health Practitioners6213
SIC code1 code
  • Services-Health Services8000
Product category
Patient Insights and Healthcare Market Research
Social media profiles3 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Patient Insight Studies
TypeTransaction Fee
Description

Healthcare organizations pay for access to verified patient insights through surveys, focus groups, and advisory boards. Companies sponsor research opportunities and compensate Real Patients for facilitating patient participation and delivering structured insights.

realpatients.com
2Research Study Facilitation
TypeTransaction Fee
Description

Real Patients matches pharmaceutical and healthcare companies with patients for research studies, earning fees for each completed engagement. Payment varies by activity type and duration.

realpatients.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain
Pricing details3 tiers
1Research Survey - 30 minute engagement
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$75 per completed survey. Activities are voluntary and patients choose which opportunities to participate in based on availability and interests.

realpatients.com
2Focus Group - 1 hour video call
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$150 per focus group. Longer, more in-depth engagement requiring video participation.

realpatients.com
3Advisory Board - Quarterly meetings
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$500 per quarterly advisory board meeting. Ongoing, higher-commitment engagement for select patients.

realpatients.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Real Patients (formerly Savvy Cooperative) operates a patient insights platform that connects a verified community of patients across 2,500+ health conditions with healthcare organizations including pharmaceutical companies, biotech firms, and medical device manufacturers. Healthcare buyers pay per engagement to access patient participation in research studies (30-minute surveys at $75), 1-hour focus group video calls ($150), and quarterly advisory board meetings ($500). Patients earn compensation for sharing experiences on their own schedule while the company facilitates matching, consent, and HIPAA-compliant data sharing.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 16,666+ patient experiences shared on platform
+1 more record
Product overview1 text field

Real Patients (formerly Savvy Cooperative) is a single unified patient insights platform that connects patients with healthcare organizations. The platform enables patients to share experiences through multiple participation channels including research studies, surveys, focus groups, and advisory boards. Patients can earn rewards for participation while maintaining privacy and control over their shared information.

Product and service4 records
1Real Patients Platform
CategoryPatient Insights Platform
Description

A patient insights platform that connects a verified community of patients across 2,500+ health conditions with healthcare organizations (pharma, biotech, medical device, and digital health companies) for paid research studies, surveys, focus groups, and advisory boards. Patients self-verify their profiles, opt into matched opportunities, and earn compensation while maintaining control over their data via HIPAA-compliant, consent-based sharing.

2Research Study Participation (30-minute survey)
CategoryPatient Insight Studies
Description

A 30-minute survey-based research engagement where verified patients answer questions about their health condition and experiences. Healthcare organizations pay $75 per completed survey, and patients receive compensation through direct deposit, PayPal, or gift cards, typically processed within 5 business days of completion.

3Focus Group Participation (1-hour video call)
CategoryPatient Insight Studies
Description

A 1-hour video call focus group where selected patients discuss their condition and treatment experiences with healthcare organization researchers. Healthcare organizations pay $150 per focus group; participation requires real-time video engagement and offers deeper, conversational insight than surveys.

4Advisory Board Participation (Quarterly meetings)
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership23 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Major pharmaceutical company utilizing Real Patients platform for patient experience research and insights to inform drug development decisions.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Pharmaceutical company engaging Real Patients for patient-centered research to understand treatment experiences and inform pipeline decisions.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Healthcare conglomerate using Real Patients for insights across pharmaceutical, medical device, and consumer health research.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Pharmaceutical company leveraging patient insights for immunology and specialty medicine development.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Global pharmaceutical company utilizing Real Patients platform for oncology, biopharmaceuticals, and rare disease research.

6Bristol-Myers Squibb
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Pharmaceutical company engaging Real Patients for oncology and immunology patient insight research.

realpatients.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

French pharmaceutical company using Real Patients for diabetes, rare diseases, and vaccine patient experience research.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Swiss pharmaceutical company engaging Real Patients for oncology and biotechnology patient insights.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Pharmaceutical company using Real Patients for diabetes, oncology, and neuroscience patient-centered research.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Swiss pharmaceutical company leveraging Real Patients for innovative patient insight methodologies.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Danish pharmaceutical company using Real Patients for diabetes and obesity treatment patient experience research.

12GSK
Strategic tierCoreTypeStrategic or Co-development Partner
Description

UK pharmaceutical company engaging Real Patients for vaccines, oncology, and infectious disease patient insights.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Japanese pharmaceutical company using Real Patients for rare diseases and gastroenterology patient experience research.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Biopharmaceutical company engaging Real Patients for HIV, liver disease, and infectious disease patient insights.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Biotechnology company using Real Patients for cardiovascular, oncology, and inflammation patient research.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

German pharmaceutical and life sciences company engaging Real Patients for healthcare innovation research.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Medical technology company using Real Patients for patient-centered medical device design and experience research.

18Boehringer Ingelheim
Strategic tierCoreTypeStrategic or Co-development Partner
Description

German pharmaceutical company engaging Real Patients for respiratory, cardiometabolic, and oncology patient insights.

realpatients.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Biotechnology company using Real Patients for ophthalmology, allergy, and oncology patient experience research.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

mRNA biotechnology company engaging Real Patients for vaccine and therapeutic patient insights.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Neuroscience biotechnology company using Real Patients for multiple sclerosis, Alzheimer's, and rare disease patient research.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Technology company partnering on healthcare innovation initiatives and patient experience programs.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Technology company engaging Real Patients for healthcare technology partnerships and ecosystem development.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Evidation operates a large-scale patient data and real-world evidence platform connecting individuals with health research opportunities. Comparable to Real Patients in selling patient insights to pharma and healthcare, but operates at significantly larger scale across both consumer health and clinical research.

TypeDirect peer
Description

Inspire runs one of the largest online patient communities and partners with pharma for patient insights and research recruitment. Directly comparable to Real Patients in operating condition-specific patient communities and monetizing them through enterprise pharma partnerships for qualitative research and real-world evidence.

TypeDirect peer
Description

WEGO Health operates a network of patient influencers and advocates that pharma companies engage for insights, advisory boards, and patient-centered research. Directly comparable to Real Patients' model of connecting pharma with verified patients for paid research engagements.

TypeDirect peer
Description

Health Union builds condition-specific online patient communities and provides pharma with patient insights, market research, and advertising solutions. Comparable to Real Patients in monetizing engaged patient communities across multiple health conditions through enterprise pharma relationships.

TypeEmerging player
Description

Inato is a clinical trial recruitment platform that helps pharma sites and sponsors find eligible patients for trials. Comparable to Real Patients in using a patient-centric matching model to serve pharma research needs, though focused specifically on clinical trial recruitment rather than qualitative insights.

6Antidote (formerly TrialReach)
TypeEmerging player
Description

Antidote is a digital health company that connects patients with clinical trials through a matching platform. Comparable in its mission to bridge patients and pharma research opportunities, though with a clinical trial focus rather than Real Patients' qualitative research and insights emphasis.

TypeEmerging player
Description

CureClick recruits patient ambassadors to drive clinical trial awareness and enrollment, monetizing through pharma sponsors. Comparable to Real Patients in using a patient-driven model to deliver value to pharma research buyers, though with a focus on trial awareness rather than paid research engagements.

TypeBroad incumbent
Description

PatientsLikeMe (acquired by UnitedHealth Group) operates one of the largest patient communities and sells de-identified real-world data and insights to pharma. Directly comparable model to Real Patients in patient community plus pharma insights, though at significantly larger scale and now backed by a major payer.

TypeEmerging player
Description

Clara Health is a patient recruitment platform for clinical trials using patient navigators and matching technology. Comparable to Real Patients in patient-centric matching for pharma research, but with a primary focus on trial enrollment rather than qualitative insights.

TypeOthers
Description

Big Health develops digital therapeutics and engages patients in clinical-grade health interventions, with pharma partnerships. Tangentially comparable to Real Patients in using patient engagement infrastructure to serve pharma, though focused on digital therapeutic delivery rather than insights and research.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers23 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Savvy

Patient Insights and Healthcare Market Researchsavvy.coop

Real Patients (formerly Savvy Cooperative) is a HIPAA-compliant patient insights platform connecting a verified community across 2,500+ health conditions with pharmaceutical, biotech, and healthcare companies for paid research engagements.

What Savvy does

Real Patients (formerly Savvy Cooperative) is a patient insights platform founded in 2016 by Jen Horonjeff, PhD and Ronnie Sharpe that connects individuals living with health conditions to pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare technology companies seeking structured patient input for research and product development. The company operates a verified patient community spanning 2,500+ health conditions, including rare diseases and chronic illnesses, with 16,666+ patient experiences contributed cumulatively. Co-founders, both chronic illness patients themselves, built the platform to address what they identified as systematic underrepresentation of authentic patient perspectives in healthcare development decisions. The company rebranded from Savvy Cooperative to Real Patients in 2025-2026 to better reflect its patient-experience mission while retaining the same operating team and values.

The platform's core technology consists of a patient profile verification system, an activity-matching algorithm that routes patients to relevant research opportunities based on health conditions, and HIPAA-compliant data protection infrastructure with bank-level encryption. Patients create verified profiles through self-service signup, are matched to research engagements, and participate through three paid activity types: 30-minute research surveys ($75 each), 1-hour video focus groups ($150 each), and quarterly advisory boards ($500 each). The platform enforces consent-based data sharing where personal contact information remains protected and only de-identified responses are shared with approved research partners.

Real Patients operates a B2B2C transactional revenue model, earning transaction fees on each completed patient engagement. Enterprise sales are conducted through direct, founder-led relationships with pharmaceutical and healthcare buyers, supplemented by earned media coverage in healthcare publications including STAT News, FierceBiotech, CNBC, and Entrepreneur Magazine, and industry conference participation. The named customer roster exceeds 20 enterprise clients concentrated in pharmaceutical (Pfizer, Merck, Johnson & Johnson, AbbVie, AstraZeneca, Bristol-Myers Squibb, Sanofi, Roche, Eli Lilly, Novartis, Novo Nordisk, GSK, Takeda, Gilead, Amgen, Bayer, Boehringer Ingelheim, Regeneron, Moderna, Biogen), medical devices (Medtronic), and technology (Amazon, Salesforce). The company has received non-equity or small-equity support from MassChallenge and Indie.vc in 2020, with no disclosed institutional venture funding rounds.

Savvy firmographics

Firmographics
Name
Savvy
Legal name
Real Patients
Website
https://savvy.coop
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
1–10 employees
Short description
Real Patients (formerly Savvy Cooperative) is a HIPAA-compliant patient insights platform connecting a verified community across 2,500+ health conditions with pharmaceutical, biotech, and healthcare companies for paid research engagements.
Ownership category
akta.pro rank

Savvy industry classification

Industry
Product category
Patient Insights and Healthcare Market Research
NAICS
Offices of Other Health Practitioners (6213)
SIC
Services-Health Services (8000)
akta.pro industry
PRIMARYHLACAEAK
Patient Community, Peer Support & Social Engagement
Healthcare & Life Sciences/Digital Health & Health IT/Patient Engagement, CRM & Experience Platforms

Keywords

  • Patient insights platform
  • Healthcare market research
  • Patient experience research
  • Clinical research services
  • Patient engagement network

Where Savvy is headquartered

Location

Headquarters

HQ city
Sunnyside
HQ country
United States
HQ region
North America

Markets served

Savvy business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

  1. Patient Insight Studies: Healthcare organizations pay for access to verified patient insights through surveys, focus groups, and advisory boards. Companies sponsor research opportunities and compensate Real Patients for facilitating patient participation and delivering structured insights.
  2. Research Study Facilitation: Real Patients matches pharmaceutical and healthcare companies with patients for research studies, earning fees for each completed engagement. Payment varies by activity type and duration.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goResearch Survey - 30 minute engagement
Unit PricingPay-as-you-goFocus Group - 1 hour video call
Unit PricingPay-as-you-goAdvisory Board - Quarterly meetings

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Savvy product offering

Product offering

Core offering

Real Patients (formerly Savvy Cooperative) operates a patient insights platform that connects a verified community of patients across 2,500+ health conditions with healthcare organizations including pharmaceutical companies, biotech firms, and medical device manufacturers. Healthcare buyers pay per engagement to access patient participation in research studies (30-minute surveys at $75), 1-hour focus group video calls ($150), and quarterly advisory board meetings ($500). Patients earn compensation for sharing experiences on their own schedule while the company facilitates matching, consent, and HIPAA-compliant data sharing.

Product overview

Real Patients (formerly Savvy Cooperative) is a single unified patient insights platform that connects patients with healthcare organizations. The platform enables patients to share experiences through multiple participation channels including research studies, surveys, focus groups, and advisory boards. Patients can earn rewards for participation while maintaining privacy and control over their shared information.

Differentiator

Problem solved

Functional benefit

Products and services

  • Real Patients Platform A patient insights platform that connects a verified community of patients across 2,500+ health conditions with healthcare organizations (pharma, biotech, medical device, and digital health companies) for paid research studies, surveys, focus groups, and advisory boards. Patients self-verify their profiles, opt into matched opportunities, and earn compensation while maintaining control over their data via HIPAA-compliant, consent-based sharing.
  • Research Study Participation (30-minute survey) A 30-minute survey-based research engagement where verified patients answer questions about their health condition and experiences. Healthcare organizations pay $75 per completed survey, and patients receive compensation through direct deposit, PayPal, or gift cards, typically processed within 5 business days of completion.
  • Focus Group Participation (1-hour video call) A 1-hour video call focus group where selected patients discuss their condition and treatment experiences with healthcare organization researchers. Healthcare organizations pay $150 per focus group; participation requires real-time video engagement and offers deeper, conversational insight than surveys.
  • Advisory Board Participation (Quarterly meetings)

Quantifiable outcome

  • 16,666+ patient experiences shared on platform
  • +1 more outcomes

Companies that use Savvy

Customer profile

Named customers23 records

Segments3 records

Ideal customer profiles3 records

Savvy technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Savvy partnerships and signals

Strategic signal

Partnerships

23 partnerships are on record, tiered core and minor.

  • PfizercoreStrategic or Co-development PartnerMajor pharmaceutical company utilizing Real Patients platform for patient experience research and insights to inform drug development decisions.
  • MerckcoreStrategic or Co-development PartnerPharmaceutical company engaging Real Patients for patient-centered research to understand treatment experiences and inform pipeline decisions.
  • Johnson & JohnsoncoreStrategic or Co-development PartnerHealthcare conglomerate using Real Patients for insights across pharmaceutical, medical device, and consumer health research.
  • AbbViecoreStrategic or Co-development PartnerPharmaceutical company leveraging patient insights for immunology and specialty medicine development.
  • AstraZenecacoreStrategic or Co-development PartnerGlobal pharmaceutical company utilizing Real Patients platform for oncology, biopharmaceuticals, and rare disease research.
  • Bristol-Myers SquibbcoreStrategic or Co-development PartnerPharmaceutical company engaging Real Patients for oncology and immunology patient insight research.
  • SanoficoreStrategic or Co-development PartnerFrench pharmaceutical company using Real Patients for diabetes, rare diseases, and vaccine patient experience research.
  • RochecoreStrategic or Co-development PartnerSwiss pharmaceutical company engaging Real Patients for oncology and biotechnology patient insights.
  • Eli LillycoreStrategic or Co-development PartnerPharmaceutical company using Real Patients for diabetes, oncology, and neuroscience patient-centered research.
  • NovartiscoreStrategic or Co-development PartnerSwiss pharmaceutical company leveraging Real Patients for innovative patient insight methodologies.
  • Novo NordiskcoreStrategic or Co-development PartnerDanish pharmaceutical company using Real Patients for diabetes and obesity treatment patient experience research.
  • GSKcoreStrategic or Co-development PartnerUK pharmaceutical company engaging Real Patients for vaccines, oncology, and infectious disease patient insights.
  • TakedacoreStrategic or Co-development PartnerJapanese pharmaceutical company using Real Patients for rare diseases and gastroenterology patient experience research.
  • GileadcoreStrategic or Co-development PartnerBiopharmaceutical company engaging Real Patients for HIV, liver disease, and infectious disease patient insights.
  • AmgencoreStrategic or Co-development PartnerBiotechnology company using Real Patients for cardiovascular, oncology, and inflammation patient research.
  • BayercoreStrategic or Co-development PartnerGerman pharmaceutical and life sciences company engaging Real Patients for healthcare innovation research.
  • MedtroniccoreStrategic or Co-development PartnerMedical technology company using Real Patients for patient-centered medical device design and experience research.
  • Boehringer IngelheimcoreStrategic or Co-development PartnerGerman pharmaceutical company engaging Real Patients for respiratory, cardiometabolic, and oncology patient insights.
  • RegeneroncoreStrategic or Co-development PartnerBiotechnology company using Real Patients for ophthalmology, allergy, and oncology patient experience research.
  • ModernacoreStrategic or Co-development PartnermRNA biotechnology company engaging Real Patients for vaccine and therapeutic patient insights.
  • BiogencoreStrategic or Co-development PartnerNeuroscience biotechnology company using Real Patients for multiple sclerosis, Alzheimer's, and rare disease patient research.
  • AmazonminorStrategic or Co-development PartnerTechnology company partnering on healthcare innovation initiatives and patient experience programs.
  • SalesforceminorStrategic or Co-development PartnerTechnology company engaging Real Patients for healthcare technology partnerships and ecosystem development.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Savvy competitors and assessment

Company assessment

Broad incumbents

  • Evidation Health: Evidation operates a large-scale patient data and real-world evidence platform connecting individuals with health research opportunities. Comparable to Real Patients in selling patient insights to pharma and healthcare, but operates at significantly larger scale across both consumer health and clinical research.
  • PatientsLikeMe: PatientsLikeMe (acquired by UnitedHealth Group) operates one of the largest patient communities and sells de-identified real-world data and insights to pharma. Directly comparable model to Real Patients in patient community plus pharma insights, though at significantly larger scale and now backed by a major payer.

Direct peers

  • Inspire: Inspire runs one of the largest online patient communities and partners with pharma for patient insights and research recruitment. Directly comparable to Real Patients in operating condition-specific patient communities and monetizing them through enterprise pharma partnerships for qualitative research and real-world evidence.
  • WEGO Health: WEGO Health operates a network of patient influencers and advocates that pharma companies engage for insights, advisory boards, and patient-centered research. Directly comparable to Real Patients' model of connecting pharma with verified patients for paid research engagements.
  • Health Union: Health Union builds condition-specific online patient communities and provides pharma with patient insights, market research, and advertising solutions. Comparable to Real Patients in monetizing engaged patient communities across multiple health conditions through enterprise pharma relationships.

Emerging players

  • Inato: Inato is a clinical trial recruitment platform that helps pharma sites and sponsors find eligible patients for trials. Comparable to Real Patients in using a patient-centric matching model to serve pharma research needs, though focused specifically on clinical trial recruitment rather than qualitative insights.
  • Antidote (formerly TrialReach): Antidote is a digital health company that connects patients with clinical trials through a matching platform. Comparable in its mission to bridge patients and pharma research opportunities, though with a clinical trial focus rather than Real Patients' qualitative research and insights emphasis.
  • CureClick: CureClick recruits patient ambassadors to drive clinical trial awareness and enrollment, monetizing through pharma sponsors. Comparable to Real Patients in using a patient-driven model to deliver value to pharma research buyers, though with a focus on trial awareness rather than paid research engagements.
  • Clara Health: Clara Health is a patient recruitment platform for clinical trials using patient navigators and matching technology. Comparable to Real Patients in patient-centric matching for pharma research, but with a primary focus on trial enrollment rather than qualitative insights.

Others

  • Sleepio / Big Health (now Big Health): Big Health develops digital therapeutics and engages patients in clinical-grade health interventions, with pharma partnerships. Tangentially comparable to Real Patients in using patient engagement infrastructure to serve pharma, though focused on digital therapeutic delivery rather than insights and research.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Savvy social profiles

Digital presence

Savvy compliance and trust

Trust signal

Compliance1 record

Savvy financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Savvy leadership team

Management profile

Number of profiles

Profiles2 records

Savvy funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Savvy M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Savvy

What does Savvy do?

Real Patients (formerly Savvy Cooperative) operates a patient insights platform that connects a verified community of patients across 2,500+ health conditions with healthcare organizations including pharmaceutical companies, biotech firms, and medical device manufacturers. Healthcare buyers pay per engagement to access patient participation in research studies (30-minute surveys at $75), 1-hour focus group video calls ($150), and quarterly advisory board meetings ($500). Patients earn compensation for sharing experiences on their own schedule while the company facilitates matching, consent, and HIPAA-compliant data sharing.

Is Savvy a public or private company?

Savvy is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Savvy founded?

Savvy was founded in 2016. It employs 1 to 10 people.

Where is Savvy based?

Savvy is headquartered in Sunnyside, United States, in the North America region.

How does Savvy make money?

Two revenue lines are on record. Patient Insight Studies are the primary driver. The others are research Study Facilitation.

Who are Savvy's main competitors?

Broad incumbents on record are Evidation Health and PatientsLikeMe. Direct peers are Inspire, WEGO Health and Health Union. Emerging players are Inato, Antidote (formerly TrialReach), CureClick and Clara Health. Sleepio / Big Health (now Big Health) is listed as an others.

Does Savvy have an API?

No public API is recorded for Savvy.

What industry is Savvy in?

Savvy's product category is Patient Insights and Healthcare Market Research. Its primary akta.pro industry code is HLACAEAK, Patient Community, Peer Support & Social Engagement. Its NAICS code is 6213 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FierceBiotechTrialbee in pact with patient-owned Savvy Cooperative to advance trialsTrialbee partnered with patient-owned Savvy Cooperative to help patients find and share experiences about clinical trials. The collaboration will initially focus on lupus and multiple sclerosis patients, who are under-recruited. Financial terms were not disclosed.PR NewswireProofPilot Announces Strategic Partnership with Savvy CooperativeProofPilot and Savvy Cooperative have announced a strategic partnership to create a turnkey model enabling clinical trial sponsors to pressure test protocol designs with patients through ProofPilot's digital protocol interface. The partnership aims to improve patient experience in clinical trials by allowing sponsors to present proposed digital workflows to the Savvy Cooperative community, helping patients better understand trial requirements before committing to participation. Sponsors can now create one-off or unlimited protocol workflows through a flexible engagement model, enabling patients and sites to collaborate on optimizing research designs.TechCrunchHealthcare co-op Savvy snags venture funding from Indie.vcSavvy, a healthcare cooperative, raised an undisclosed amount from Indie.vc. The cooperative, which shares profits with patients, is bootstrapped and plans to use the funding to expand offerings and support more companies. Indie.vc founder Bryce Roberts said the co-op represents shared ownership and aligned incentives.PR NewswireDigital Therapeutics Are On the Rise, But Patients Worried Their Privacy Could Be At Risk, New Research RevealsInnovation consultancy Enspektos, LLC released research findings showing that digital therapeutics, including prescription drugs with embedded sensors and mobile health applications, are rapidly growing in scope and importance globally as of Q1 2018. The research, conducted in partnership with Savvy Cooperative through an online survey of over 230 patients, revealed that more than one-third of respondents are concerned these technologies will be used to track their behavior invasively or that their data will be sold to third parties without permission. The report suggests that negative perceptions may be influenced by recent revelations about Facebook's improper user data practices.